| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 130.0 | 124.7 |
| Gross profit | 53.1 | 43.6 |
| Profit before tax | -17.4 | -13.5 |
| Net income | -28.0 | -25.8 |
| EPS (diluted, $ a share) | $-0.14 | $-0.13 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +4.2% |
|---|---|
| Gross margin | 40.8% |
| Operating margin | 3.5% |
10-Q filed with the SEC, OTC: AAWH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Ascend Wellness Holdings, Inc.: key numbers
- Share price
- $0.3414Close, Nov 16
- Market cap
- $69.4M
- Shares outstanding
- 203.42MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Medicinal Chemicals & Botanical ProductsSIC 2833
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Ascend Wellness Holdings, Inc.
All →Ascend Wellness Holdings Financial Results
Ascend Wellness Holdings reported Q3 2026 net revenue of $130.0 million, a 4.2% year-over-year increase, driven by record retail transaction volumes. The company generated $31.1 million in Adjusted EBITDA and ended the quarter with 56 retail stores, subsequently expanding to 61 locations. Management highlighted strong operating leverage and positive cash flow from operations despite a significant semi-annual interest payment.
- Term
- Q3 2026
“Our third quarter results demonstrate the strength of our retail platform and the growing demand for our brands. We achieved record transaction volume and expanded our footprint ahead of schedule, positioning Ascend for continued growth as we optimize our operations and prepare for potential regulatory shifts in the industry.”
John Redman, CEO